Both in Pharmaceuticals
Evommune vs Vanda Pharmaceuticals
Over the past year EVMN returned −58.7% and VNDA returned +14.1%; their daily moves had a correlation of 0.05.
EVMN −58.7% VNDA +14.1%Growth of $1, one year, split-adjusted
| Metric | EVMN | VNDA |
|---|---|---|
| Price | $8.35 | $5.03 |
| Market cap | $303.0M | $304.1M |
| Today | −0.48% | −2.71% |
| 1 month | −36.9% | −4.9% |
| 6 months | −62.0% | −24.4% |
| Year to date | −51.2% | −43.0% |
| 1 year | — | −1.4% |
| Revenue growth (YoY) | — | −3.9% |
| Gross margin | — | 93.0% |
| Net margin | — | −123.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.4× |
| Net cash | $200.4M | $166.9M |
| Dividend yield | — | — |
| Volatility (60d) | 74.5% | 39.6% |
| Short % of float | 12.5% | 15.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).